Adalat CR



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 57.1%
Blood Pressure Management 14.3%
Essential Hypertension 14.3%
Gestational Hypertension 14.3%
Erythema Multiforme 25.0%
Primary Hyperaldosteronism 25.0%
Toxicity To Various Agents 25.0%
Umbilical Cord Abnormality 25.0%
Secondary
Hypertension 23.1%
Product Used For Unknown Indication 20.0%
Essential Hypertension 9.2%
Foetal Exposure During Pregnancy 9.2%
Dermatitis Atopic 4.6%
Embolic Stroke 4.6%
Hepatitis C 4.6%
Gastric Ulcer 3.1%
Hyperuricaemia 3.1%
Hypothyroidism 3.1%
Atrial Fibrillation 1.5%
Chronic Hepatitis C 1.5%
Chronic Myeloid Leukaemia 1.5%
Chronic Obstructive Pulmonary Disease 1.5%
Diabetes Mellitus 1.5%
Diuresis 1.5%
Fluid Replacement 1.5%
Gestational Hypertension 1.5%
Gout 1.5%
Hyperlipidaemia 1.5%
Rash 10.5%
Agranulocytosis 5.3%
Diarrhoea 5.3%
Foetal Exposure During Pregnancy 5.3%
Pneumonia 5.3%
Pre-eclampsia 5.3%
Premature Labour 5.3%
Primary Hyperaldosteronism 5.3%
Pruritus 5.3%
Rash Vesicular 5.3%
Renal Failure Acute 5.3%
Renal Impairment 5.3%
Rhabdomyolysis 5.3%
Tendon Rupture 5.3%
Tracheomalacia 5.3%
Tremor 5.3%
Vaginal Haemorrhage 5.3%
Ventricular Extrasystoles 5.3%
Concomitant
Hypertension 23.3%
Chronic Hepatitis C 12.3%
Prophylaxis 10.5%
Product Used For Unknown Indication 9.4%
Nephrogenic Anaemia 8.2%
Diabetes Mellitus 5.3%
Insomnia 3.2%
Hepatitis C 3.1%
Glomerulonephritis Chronic 3.0%
Rheumatoid Arthritis 2.9%
Cardiac Failure 2.7%
Constipation 2.7%
Hyperlipidaemia 2.1%
Type 2 Diabetes Mellitus 2.1%
Gastritis 1.9%
Colon Cancer Metastatic 1.5%
Hyperphosphataemia 1.5%
Angina Pectoris 1.4%
Diabetic Nephropathy 1.4%
Hyperuricaemia 1.4%
Renal Impairment 15.5%
Haemoglobin Decreased 9.3%
Vomiting 9.3%
Rash 7.8%
White Blood Cell Count Decreased 6.2%
Hypertension 5.4%
Pneumonia 5.4%
Renal Failure Acute 5.4%
Pyrexia 4.7%
Blood Creatinine Increased 3.9%
Interstitial Lung Disease 3.9%
Death 3.1%
Renal Disorder 3.1%
Retinal Haemorrhage 3.1%
Hypertensive Crisis 2.3%
Hypoglycaemia 2.3%
Neck Pain 2.3%
Renal Failure 2.3%
Rheumatoid Arthritis 2.3%
Somnolence 2.3%